| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antibiotic lock therapy for the treatment of peripherally inserted central venous catheter-related bloodstream infection in patients with hematological malignancies: a single center retrospective study
|
Zhang, Qin
|
|
|
104 |
Suppl 1 |
p. 1975-1984
|
artikel
|
| 2 |
A phase 1 study of durvalumab as monotherapy or combined with tremelimumab with or without azacitidine in patients with myelodysplastic syndrome
|
Garcia-Manero, Guillermo
|
|
|
104 |
Suppl 1 |
p. 1577-1585
|
artikel
|
| 3 |
A predictive algorithm involving lactate dehydrogenase to serum creatinine ratio may assist in identifying patients with thrombotic thrombocytopenic purpura
|
Chen, Xuduan
|
|
|
104 |
Suppl 1 |
p. 3165-3172
|
artikel
|
| 4 |
A randomized controlled trial of conventional GVHD prophylaxis with or without teprenone for the prevention of severe acute GVHD
|
Kitamura, Wataru
|
|
|
104 |
Suppl 1 |
p. 1917-1929
|
artikel
|
| 5 |
A review on disease modifying pharmacologic therapies for sickle cell disease
|
Mahadevia, Himil
|
|
|
104 |
Suppl 1 |
p. 881-893
|
artikel
|
| 6 |
Association between radiotherapy and overall survival or cancer-specific survival in patients with solitary plasmacytoma of bone at pre-B cell grade: a real-world study using the SEER database
|
Wu, Qiong
|
|
|
104 |
Suppl 1 |
p. 2461-2468
|
artikel
|
| 7 |
Azacitidine in combination with HAG for newly diagnosed and relapsed/refractory AML: a prospective cohort study
|
Pan, Hong
|
|
|
104 |
Suppl 1 |
p. 1597-1604
|
artikel
|
| 8 |
Basophilia and eosinophilia in polycythemia vera and essential thrombocythemia: clinical, genotype, and prognostic correlates
|
Faldu, Priyansh
|
|
|
104 |
Suppl 1 |
p. 3223-3234
|
artikel
|
| 9 |
Belumosudil in pediatric patients with chronic graft-versus-host disease after failed multi-line therapy: a case series
|
Chen, Wenting
|
|
|
104 |
Suppl 1 |
p. 1241-1247
|
artikel
|
| 10 |
Central nervous system involvement in Waldenström macroglobulinemia: a comparative population-based study of Bing-Neel syndrome and histological transformation
|
Østergaard, Simon
|
|
|
104 |
Suppl 1 |
p. 1007-1014
|
artikel
|
| 11 |
Clinical characteristics of lymphoma patients presenting with fever of unknown origin misdiagnosed with connective tissue diseases
|
Zhang, Xuehan
|
|
|
104 |
Suppl 1 |
p. 1157-1164
|
artikel
|
| 12 |
Clinical usefulness of next-generation sequencing-based target gene sequencing in diagnosis of inherited bone marrow failure syndrome
|
Kwon, Young Dai
|
|
|
104 |
Suppl 1 |
p. 2693-2706
|
artikel
|
| 13 |
Clinicopathological and prognostic significance of DDX41 mutation in myeloid neoplasms: a systematic review and meta-analysis
|
Miao, Liying
|
|
|
104 |
Suppl 1 |
p. 2581-2591
|
artikel
|
| 14 |
Clinicopathological features and prognostic factors of AIDS-related lymphoma: a retrospective single-center study in China
|
Liang, Ying
|
|
|
104 |
Suppl 1 |
p. 3411-3422
|
artikel
|
| 15 |
Combination of disease burden before allogeneic transplantation and early post-transplant minimal residual disease predicts survival in patients with acute myeloid leukemia
|
Stock, Claudia Núñez-Torrón
|
|
|
104 |
Suppl 1 |
p. 2469-2481
|
artikel
|
| 16 |
Combined heterozygosity for hemoglobin Paksé, α-thalassemia and for hemoglobin E, β- thalassemia ̵ first appearance in Europe
|
Schnedl, Wolfgang J.
|
|
|
104 |
Suppl 1 |
p. 2059-2064
|
artikel
|
| 17 |
Comparative efficacy of venetoclax-based regiments in the management of chronic lymphocytic leukemia: a systematic review and metanalysis
|
Jamil, Abdur
|
|
|
104 |
Suppl 1 |
p. 1387-1397
|
artikel
|
| 18 |
COVID-19 infection in children with blood cancer: A systematic review
|
Alhumaid, Saad
|
|
|
104 |
Suppl 1 |
p. 1203-1230
|
artikel
|
| 19 |
Deciphering clinical features and treatment patterns of thrombocytopenic myelodysplastic syndromes
|
Galli, Nicole
|
|
|
104 |
Suppl 1 |
p. 3261-3269
|
artikel
|
| 20 |
Efficacy and influencing factors of immunosuppressive therapy for pure red cell aplasia: meta-analysis and systematic review
|
Yusup, Muyassar
|
|
|
104 |
Suppl 1 |
p. 2189-2206
|
artikel
|
| 21 |
Efficacy and prognosis of allogeneic hematopoietic stem cell transplantation in aggressive NK-cell leukemia: a meta-analysis
|
Cao, Shuya
|
|
|
104 |
Suppl 1 |
p. 3433-3445
|
artikel
|
| 22 |
Efficacy and safety analysis of China’s first 10% IVIg (RonsenGlob) therapy in treating adult ITP
|
Fang, Lijun
|
|
|
104 |
Suppl 1 |
p. 2643-2651
|
artikel
|
| 23 |
Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in newly diagnosed and relapsed/refractory acute myeloid leukemia: results of a single center study
|
Zhu, Ting
|
|
|
104 |
Suppl 1 |
p. 2745-2753
|
artikel
|
| 24 |
Efficacy and safety of isatuximab monotherapy to treat relapsed or refractory multiple myeloma: a pooled analysis of clinical trials
|
Dimopoulos, Meletios
|
|
|
104 |
Suppl 1 |
p. 2337-2350
|
artikel
|
| 25 |
Efficacy of venetoclax combined with homoharringtonine and cytarabine for younger adults with newly diagnosed AML
|
Song, Bao-Quan
|
|
|
104 |
Suppl 1 |
p. 1617-1622
|
artikel
|
| 26 |
Emerging treatment approaches for VEXAS syndrome: a systematic review and meta-analysis
|
Kilic, Berkay
|
|
|
104 |
Suppl 1 |
p. 2617-2630
|
artikel
|
| 27 |
Epidemiological and clinical characteristics of children and young adults with Glanzmann’s thrombasthenia in upper Egypt: a multicenter cross-sectional study
|
Khalifa, Gehan Lotfy Abdel Hakeem
|
|
|
104 |
Suppl 1 |
p. 1961-1973
|
artikel
|
| 28 |
Epidemiologic sequential analysis of pure red blood cell aplasia and T-cell large granular lymphocyte leukemia in Korea
|
Park, Sooyong
|
|
|
104 |
Suppl 1 |
p. 2881-2887
|
artikel
|
| 29 |
Epidemiologic trends for pediatric Hodgkin and non-Hodgkin lymphomas: a U.S. population-based study
|
Cheng, Weishi
|
|
|
104 |
Suppl 1 |
p. 3299-3307
|
artikel
|
| 30 |
Epidemiology and survival of patients with primary lymphoma of bone: a large retrospective cohort study
|
Liang, Xiaojie
|
|
|
104 |
Suppl 1 |
p. 3345-3358
|
artikel
|
| 31 |
Evaluated NSUN3 in reticulocytes from HbH-CS disease that reflects cellular stress in erythroblasts
|
Liu, Haodong
|
|
|
104 |
Suppl 1 |
p. 2207-2219
|
artikel
|
| 32 |
Favorable correlation between neutrophil percentages obtained using automated hematology analyzers and microscopic examinations in malignant lymphoma patients receiving chemotherapy
|
Hosoi, Hiroki
|
|
|
104 |
Suppl 1 |
p. 2305-2316
|
artikel
|
| 33 |
Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study
|
Dartigeas, Caroline
|
|
|
104 |
Suppl 1 |
p. 1079-1093
|
artikel
|
| 34 |
Further strategies after immune checkpoint inhibitors in relapsed/refractory Hodgkin lymphoma: salvage treatments and consolidation with transplantation, experience in daily clinical practice
|
Pellegrini, Cinzia
|
|
|
104 |
Suppl 1 |
p. 1757-1764
|
artikel
|
| 35 |
Genetic abnormalities predict outcomes in patients with core binding factor acute myeloid leukemia
|
Yu, Shunjie
|
|
|
104 |
Suppl 1 |
p. 997-1006
|
artikel
|
| 36 |
Genetic analysis of a pedigree with hereditary coagulation factor XII deficiency
|
Fang, Weiwei
|
|
|
104 |
Suppl 1 |
p. 1281-1289
|
artikel
|
| 37 |
Genetic variants in NHEJ1 and related DNA repair disorders: insights into phenotypic heterogeneity and links to hypoplastic myelodysplastic syndromes and familial hematological malignancies susceptibility
|
Elbadry, Mahmoud I.
|
|
|
104 |
Suppl 1 |
p. 1633-1653
|
artikel
|
| 38 |
Genomic mutation profile and metabolic alterations in diffuse large B-cell lymphoma with abdominal bulky mass
|
Zhang, Han
|
|
|
104 |
Suppl 1 |
p. 3359-3375
|
artikel
|
| 39 |
Gilteritinib versus salvage chemotherapy in predominantly Asian patients with relapsed/refractory FLT3-mutated acute myeloid leukemia: a regional analysis of COMMODORE in China, South-East Asia, and Russia
|
Jiang, Bin
|
|
|
104 |
Suppl 1 |
p. 1563-1575
|
artikel
|
| 40 |
Global, regional and national temporal trends in incidence and mortality of non-Hodgkin lymphoma from 1992 to 2021: an age-period-cohort analysis
|
Tang, Shanshan
|
|
|
104 |
Suppl 1 |
p. 1679-1696
|
artikel
|
| 41 |
GPVI-dependent functional competence of buffy coat platelet concentrates (PCs) versus PRP-derived PCs: insights into the effects of biomechanical forces during platelet preparation
|
Hosseini, Ehteramolsadat
|
|
|
104 |
Suppl 1 |
p. 2973-2988
|
artikel
|
| 42 |
Health-related quality of life in patients with aggressive non-Hodgkin lymphoma: results from the PETAL trial
|
Dührsen, Ulrich
|
|
|
104 |
Suppl 1 |
p. 2831-2845
|
artikel
|
| 43 |
Health-related quality of life with daratumumab, bortezomib, melphalan, and prednisone versus bortezomib, melphalan, and prednisone alone in transplant-ineligible patients with newly diagnosed multiple myeloma: analysis of the phase 3 OCTANS study
|
Fu, Weijun
|
|
|
104 |
Suppl 1 |
p. 2765-2776
|
artikel
|
| 44 |
Hematopoietic stem cell transplantation and immunosuppressive therapy: implications of clonal haematopoiesis
|
Tan, Zhengwei
|
|
|
104 |
Suppl 1 |
p. 1877-1886
|
artikel
|
| 45 |
Identification of molecular clusters and a risk prognosis model for diffuse large B-cell lymphoma based on lactate metabolism-related genes
|
Zhang, Jie
|
|
|
104 |
Suppl 1 |
p. 2847-2867
|
artikel
|
| 46 |
Immune responses after one versus two Influenza A/B vaccinations in patients with multiple myeloma
|
Enssle, Julius C.
|
|
|
104 |
Suppl 1 |
p. 2813-2821
|
artikel
|
| 47 |
Immunoglobulin heavy/light chain assay in the diagnosis, monitoring and follow-up of renal AL amyloidosis patients at different disease stages
|
Wang, Yujie
|
|
|
104 |
Suppl 1 |
p. 2287-2295
|
artikel
|
| 48 |
Impact of BCOR/BCORL1 mutation on outcomes of allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia patients
|
Zhou, YunXia
|
|
|
104 |
Suppl 1 |
p. 2631-2642
|
artikel
|
| 49 |
Impact of ETV6 mutations on clinical outcomes in acute myeloid leukemia: a real-world retrospective cohort study
|
Li, Xueqian
|
|
|
104 |
Suppl 1 |
p. 3271-3279
|
artikel
|
| 50 |
Impact of graft-versus-host disease on outcomes of cord blood transplantation according to HLA disparity and its prophylaxis type
|
Yokoyama, Hisayuki
|
|
|
104 |
Suppl 1 |
p. 2905-2913
|
artikel
|
| 51 |
Impact of induction regimens on stem cell mobilization yields in newly diagnosed multiple myeloma
|
Kwon, Soyean
|
|
|
104 |
Suppl 1 |
p. 2297-2304
|
artikel
|
| 52 |
Impact of secondary-type mutations on the prognosis of AML patients with NPM1 mutation: a systematic review and meta-analysis
|
Wang, Tao
|
|
|
104 |
Suppl 1 |
p. 3103-3115
|
artikel
|
| 53 |
Improved survival in older patients with myeloid malignancies undergoing haploidentical peripheral blood stem cell transplantation with low-dose anti-thymocyte globin (ATG)/post-cyclophosphamide (PTCy)-based regimen for graft-versus-host disease prophylaxis
|
Jia, Yannan
|
|
|
104 |
Suppl 1 |
p. 1857-1866
|
artikel
|
| 54 |
Improving outcome prediction in indolent ATL by subdividing intermediate risk into low- and high-intermediate groups
|
Fuji, Shigeo
|
|
|
104 |
Suppl 1 |
p. 2429-2436
|
artikel
|
| 55 |
Inborn errors of immunity presenting with lymphoproliferation: lessons from a case series
|
Costagliola, Giorgio
|
|
|
104 |
Suppl 1 |
p. 3117-3127
|
artikel
|
| 56 |
Incidence and risk factors of severe infections in diffuse large B-cell lymphoma patients undergoing immunochemotherapy
|
Zhao, Haiqiu
|
|
|
104 |
Suppl 1 |
p. 2869-2879
|
artikel
|
| 57 |
Incidence of pneumonia among bruton tyrosine kinase inhibitors in chronic lymphocytic leukemia: a systematic review and meta-analysis of clinical trials
|
Mahadevia, Himil
|
|
|
104 |
Suppl 1 |
p. 2605-2616
|
artikel
|
| 58 |
Income and education affect prognosis and treatment in symptomatic myeloma
|
Larfors, Gunnar
|
|
|
104 |
Suppl 1 |
p. 565-572
|
artikel
|
| 59 |
Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6)
|
Fuhrmann, Stephan
|
|
|
104 |
Suppl 1 |
p. 2317-2325
|
artikel
|
| 60 |
Low levels of CD3 + and CD8 + T cells in peripheral blood can predict poor efficacy of first-line chemotherapy in patients with angioimmunoblastic T cell lymphoma
|
Liu, Yanfei
|
|
|
104 |
Suppl 1 |
p. 1705-1712
|
artikel
|
| 61 |
Management of paroxysmal nocturnal hemoglobinuria with low-level hemolysis in pregnancy– a report of two cases
|
Riedl, Julia
|
|
|
104 |
Suppl 1 |
p. 1249-1253
|
artikel
|
| 62 |
Metabolic parameter of baseline 18 F-FDG PET/CT with PINK models improve the prediction of treatment outcome in extranodal NK/T-cell lymphoma treated with P-GEMOX chemotherapy
|
Huang, Cheng
|
|
|
104 |
Suppl 1 |
p. 1069-1078
|
artikel
|
| 63 |
Metabolic reprogramming induced by PSMA4 overexpression facilitates bortezomib resistance in multiple myeloma
|
Yu, Han
|
|
|
104 |
Suppl 1 |
p. 1023-1037
|
artikel
|
| 64 |
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis
|
Morath, Olga
|
|
|
104 |
Suppl 1 |
p. 2755-2763
|
artikel
|
| 65 |
Multisystem Langerhans cell histiocytosis in a pediatric patient: a rare case report with literature review and future directions
|
Hanifa, Hamdah
|
|
|
104 |
Suppl 1 |
p. 3067-3072
|
artikel
|
| 66 |
New FDG-PET/CT interpretation criteria (Huaxi criteria) for response assessment in patients with nasal-type extranodal NK/T-cell lymphoma: development and validation
|
Li, Li
|
|
|
104 |
Suppl 1 |
p. 3377-3387
|
artikel
|
| 67 |
Novel AK-1 gene variants combined with thalassemia causing rare hereditary non-spherocytic hemolytic anemia in a Chinese family
|
Chen, Lizhu
|
|
|
104 |
Suppl 1 |
p. 2035-2043
|
artikel
|
| 68 |
Novel use of Siltuximab in a patient with VEXAS Syndrome
|
Cáceres-Nazario, Beatriz
|
|
|
104 |
Suppl 1 |
p. 1259-1267
|
artikel
|
| 69 |
Optimising survivorship post-BMT: healthcare professionals’ perceptions of long-term care
|
McErlean, Gemma
|
|
|
104 |
Suppl 1 |
p. 2927-2935
|
artikel
|
| 70 |
Outcomes in patients with acute myeloid leukemia older than 70 years within the last 30 years, a single center experience
|
Schulz, Felicitas
|
|
|
104 |
Suppl 1 |
p. 231-239
|
artikel
|
| 71 |
Overview of 1q abnormalities in multiple myeloma: scientific opinions from Italian experts
|
D’Agostino, Mattia
|
|
|
104 |
Suppl 1 |
p. 1443-1458
|
artikel
|
| 72 |
Patient-reported outcomes in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab and approved C5 inhibitors in the phase III COMMODORE 2 and 1 studies
|
Panse, Jens
|
|
|
104 |
Suppl 1 |
p. 3199-3212
|
artikel
|
| 73 |
Phase-1 study of vamotinib (PF-114), a 3rd generation BCR::ABL1 tyrosine kinase-inhibitor, in chronic myeloid leukaemia
|
Turkina, Anna
|
|
|
104 |
Suppl 1 |
p. 2707-2715
|
artikel
|
| 74 |
Platelet-to-Neutrophil ratio as a predictor of risk of complications in sickle cell disease: a valuable insight for resource-limited settings
|
Efobi, Chilota
|
|
|
104 |
Suppl 1 |
p. 2663-2669
|
artikel
|
| 75 |
Polatuzumab Vedotin, zanubrutinib and rituximab (Pola-ZR) achieved rapid and deep response in untreated frail and elderly DLBCL
|
Ren, Yuhong
|
|
|
104 |
Suppl 1 |
p. 2823-2830
|
artikel
|
| 76 |
Post-transplant cyclophosphamide versus anti-thymocyte globulin in haploidentical stem cell transplantation: a systematic review and meta-analysis
|
Jin, Xuelian
|
|
|
104 |
Suppl 1 |
p. 1317-1328
|
artikel
|
| 77 |
Prognostic role of interim PET-CT demonstrating partial metabolic response in diffuse large B-Cell lymphoma: a retrospective study
|
Gao, Jinjie
|
|
|
104 |
Suppl 1 |
p. 2777-2786
|
artikel
|
| 78 |
Prognostic value of CD47 overexpression measured by flow cytometry in acute myeloid leukemia
|
Sammartano, Vincenzo
|
|
|
104 |
Suppl 1 |
p. 2737-2743
|
artikel
|
| 79 |
Prognostic value of circular RNAs expression and their correlation with clinicopathological features in acute myeloid leukemia: a systematic review and meta-analysis
|
Mirazimi, Yasin
|
|
|
104 |
Suppl 1 |
p. 2095-2124
|
artikel
|
| 80 |
Racial disparities in cardiovascular manifestations among patients with sickle cell trait: analysis of national inpatient sample data (2016–2020)
|
Keesari, Praneeth Reddy
|
|
|
104 |
Suppl 1 |
p. 1501-1506
|
artikel
|
| 81 |
Real-world characteristics and outcomes of patients with multiple myeloma treated with belantamab mafodotin: a German claims data study
|
Luna, Jaime
|
|
|
104 |
Suppl 1 |
p. 3289-3298
|
artikel
|
| 82 |
Real-world data on the use of subcutaneous daratumumab plus bortezomib, thalidomide, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma
|
Hungria, Vania
|
|
|
104 |
Suppl 1 |
p. 2787-2798
|
artikel
|
| 83 |
Real-world evidence of Carfilzomib, Lenalidomide and Dexamethasone (KRD) Scheme in patients with relapsed / refractory multiple myeloma
|
Garcia-Guiñon, Antoni
|
|
|
104 |
Suppl 1 |
p. 1177-1186
|
artikel
|
| 84 |
Relapses and outcomes of systemic chemo-free therapies combined with intravitreous methotrexate in isolated primary vitreoretinal lymphoma: an analysis based on two prospective cohort studies
|
Chen, Hongyun
|
|
|
104 |
Suppl 1 |
p. 3403-3410
|
artikel
|
| 85 |
Revealing silent alpha-thalassemia: characterization of novel HBA1 deletion and missense mutation in Tunisian families
|
Amri, Yessine
|
|
|
104 |
Suppl 1 |
p. 3173-3182
|
artikel
|
| 86 |
Risk factors and a prediction model of severe asparaginase-associated pancreatitis in children
|
Lin, Long
|
|
|
104 |
Suppl 1 |
p. 1015-1022
|
artikel
|
| 87 |
Role of IRF4 in mediating plasmablast differentiation in diffuse large B-cell lymphomas via mTORC1 pathway
|
Gao, Jingjing
|
|
|
104 |
Suppl 1 |
p. 2449-2459
|
artikel
|
| 88 |
Ruxolitinib treatment outcomes in acute graft-versus-host disease (aGvHD) in a real-world setting in Finland
|
Martelin, Eeva
|
|
|
104 |
Suppl 1 |
p. 3451-3458
|
artikel
|
| 89 |
Selective efficacy of venetoclax in unfit patients with acute myeloid leukemia with myelodysplasia-related gene mutations under low-intensity therapy
|
Lin, Jinya
|
|
|
104 |
Suppl 1 |
p. 2717-2729
|
artikel
|
| 90 |
Sequential combined bypassing therapy in haemophilia patients with high titer inhibitors: surgical experience
|
Ding, Bingjie
|
|
|
104 |
Suppl 1 |
p. 1949-1960
|
artikel
|
| 91 |
Sickle cell disease and opioid overdose outcomes in the United States: a nationwide analysis
|
Bode, Anna L.
|
|
|
104 |
Suppl 1 |
p. 1551-1561
|
artikel
|
| 92 |
Successful treatment of multi-hit TP53-mutated myelodysplastic syndromes with erythroid predominance using allogeneic stem cell transplantation and ruxolitinib
|
Oshima, Seigi
|
|
|
104 |
Suppl 1 |
p. 3517-3522
|
artikel
|
| 93 |
Targeted antineoplastic therapy in critically ill cancer patients: a multicenter analysis of the iCHOP registry
|
Storck, Anthea
|
|
|
104 |
Suppl 1 |
p. 2937-2946
|
artikel
|
| 94 |
Targeting refractory diffuse large B cell lymphoma by CAR-WEE1 T-cells: In vitro evaluation
|
Ahmed, Hadeer Mohamed
|
|
|
104 |
Suppl 1 |
p. 1833-1844
|
artikel
|
| 95 |
TGFBI regulates the TGF-β pathway to affect the malignant progression and cisplatin sensitivity in diffuse large B-cell lymphoma
|
Wu, Lili
|
|
|
104 |
Suppl 1 |
p. 1165-1176
|
artikel
|
| 96 |
The efficacy and safety of nelarabine in relapsed or refractory T-cell acute lymphoblastic leukemia: a systematic review and meta-analysis
|
Shakeel, Laiba
|
|
|
104 |
Suppl 1 |
p. 1139-1155
|
artikel
|
| 97 |
The efficacy of immunosuppressive therapy with or without thrombopoietin receptor agonist in elderly patients with severe aplastic anemia
|
Li, Jianping
|
|
|
104 |
Suppl 1 |
p. 1515-1525
|
artikel
|
| 98 |
The expression patterns and prognostic significance of PD-1 and TIM-3 on T cells and the differentiated subsets in acute myeloid leukemia
|
Sun, Kai
|
|
|
104 |
Suppl 1 |
p. 3235-3250
|
artikel
|
| 99 |
The impact of obesity and its related underlying diseases on cytokine release syndrome and the efficacy of CAR-T therapy in treating B-cell malignancies
|
Du, Mengyi
|
|
|
104 |
Suppl 1 |
p. 1887-1895
|
artikel
|
| 100 |
The molecular impact of miR-326 in acute lymphoblastic leukemia and its cross talk with P53
|
Shafieizadegan, Saba
|
|
|
104 |
Suppl 1 |
p. 2417-2427
|
artikel
|
| 101 |
The outcomes of second haploidentical donor transplantation for graft failure in patients with severe aplastic anaemia
|
Lin, Ming-Hao
|
|
|
104 |
Suppl 1 |
p. 3469-3476
|
artikel
|
| 102 |
The outcomes of the obesity paradox in pulmonary embolism: a study of the national inpatient sample database from 2016 to 2020
|
Garg, Ayushi
|
|
|
104 |
Suppl 1 |
p. 1187-1193
|
artikel
|
| 103 |
Thromboembolism in adult patients with acute promyelocytic leukemia: clinical characteristics, risk factors, and a predictive nomogram
|
Hao, Lixia
|
|
|
104 |
Suppl 1 |
p. 973-983
|
artikel
|
| 104 |
TIGIT/PVR axis regulates anti-tumor immunity in hematologic malignancies
|
Meng, Fanqiao
|
|
|
104 |
Suppl 1 |
p. 1415-1426
|
artikel
|
| 105 |
Topological importance of CD8+ T-cell enrichment in the tumor microenvironment of classic Hodgkin lymphoma
|
Takahashi, Hiromichi
|
|
|
104 |
Suppl 1 |
p. 1047-1057
|
artikel
|
| 106 |
TP53 deletion is associated with poor survival of adult ALK-positive ALCL patients receiving CHOP-based chemotherapy
|
Katagiri, Seiichiro
|
|
|
104 |
Suppl 1 |
p. 1801-1806
|
artikel
|
| 107 |
Transformed to myelofibrosis is a risk factor for pulmonary hypertension in Philadelphia chromosome-negative myeloproliferative neoplasms
|
Suolitiken, Dina
|
|
|
104 |
Suppl 1 |
p. 2279-2285
|
artikel
|
| 108 |
Treatment outcomes of BTK inhibitors and venetoclax with or without anti-CD20 monoclonal antibody in relapsed or refractory mantle cell lymphoma
|
Yang, Ping
|
|
|
104 |
Suppl 1 |
p. 2361-2371
|
artikel
|
| 109 |
Treatment patterns and healthcare resource utilization in ruxolitinib-treated patients with myelofibrosis with and without anemia: a real-world analysis
|
Liu, Tom
|
|
|
104 |
Suppl 1 |
p. 1605-1616
|
artikel
|
| 110 |
Treatment-related leukoencephalopathy in adults with central nervous system lymphoma: a retrospective analysis of 126 patients
|
Masuda, Yasutaka
|
|
|
104 |
Suppl 1 |
p. 1095-1104
|
artikel
|
| 111 |
Trends in the epidemiology of intravascular device-associated bacteremia among French hematology patients: insights from the SPIADI prospective multicenter study, 2020–2024
|
van der Mee-Marquet, Nathalie
|
|
|
104 |
Suppl 1 |
p. 1231-1240
|
artikel
|
| 112 |
Understanding the role of asthma in acute chest syndrome: a comparative analysis of patients with and without asthma
|
Rodriguez, Nehemias Guevara
|
|
|
104 |
Suppl 1 |
p. 2179-2187
|
artikel
|
| 113 |
Unraveling the multifaceted roles of peroxiredoxins in sickle cell anemia: implications in redox and inflammation adaptations
|
Romanello, Karen Simone
|
|
|
104 |
Suppl 1 |
p. 2265-2277
|
artikel
|
| 114 |
Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm
|
Lee, Benjamin J.
|
|
|
104 |
Suppl 1 |
p. 2069-2071
|
artikel
|
| 115 |
Venous thromboembolic risk in hematological hospitalized patients: a retrospective study
|
Cordella, Stefano
|
|
|
104 |
Suppl 1 |
p. 2963-2971
|
artikel
|
| 116 |
Whole brain radiotherapy combined with CART-cell therapy for relapsed/refractory central nervous system B-cell lymphoma
|
Shi, Hui
|
|
|
104 |
Suppl 1 |
p. 2495-2505
|
artikel
|
| 117 |
Zinc level and its impact on the phenotype of sickle cell disease
|
Youssry, Ilham
|
|
|
104 |
Suppl 1 |
p. 3213-3221
|
artikel
|
Tijdschrift beschrijving